Parkinson's disease. Modification by 5-hydroxytryptophan.

Chase, T N

Parkinson's disease. Modification by 5-hydroxytryptophan. [electronic resource] - Neurology May 1972 - 479-84 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article

0028-3878

10.1212/wnl.22.5.479 doi


5-Hydroxytryptophan--therapeutic use
Adult
Aged
Brain--metabolism
Carboxy-Lyases--antagonists & inhibitors
Clinical Trials as Topic
Drug Synergism
Evaluation Studies as Topic
Extrapyramidal Tracts--drug effects
Female
Humans
Hydrazines--therapeutic use
Hydroxyindoleacetic Acid--cerebrospinal fluid
Male
Methyldopa--therapeutic use
Middle Aged
Parkinson Disease--cerebrospinal fluid
Phenylacetates--cerebrospinal fluid
Placebos
Serotonin--metabolism